Avacta Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

June 11, 2025

Simply Wall St

Avacta Group (LON:AVCT) Full Year 2024 Results

Key Financial Results

Net loss: UK£29.4m (loss widened by 18% from FY 2023).
UK£0.085 loss per share.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

revenue-and-expenses-breakdown — AIM:AVCT Revenue and Expenses Breakdown June 11th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Avacta Group Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) missed analyst estimates by 72%.

In the last 12 months, the only revenue segment was Therapeutics contributing UK£113.0k. The largest operating expense was General & Administrative costs, amounting to UK£16.2m (51% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of UK£2.38m. Explore how AVCT's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to stay flat during the next 2 years compared to a 9.4% growth forecast for the Biotechs industry in the United Kingdom.

Performance of the British Biotechs industry.

The company's shares are up 4.3% from a week ago.

Risk Analysis

You should learn about the 5 warning signs we've spotted with Avacta Group (including 3 which shouldn't be ignored).

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.